Femmesafe Cancer Screening Today

Trucheck – Femmesafe Cancer Screening (Breast, Ovaries, Uterus, Endometrium, Cervix) from Datar Cancer Genetics is a revolutionary multi-cancer screening test. It is based on a simple fasted blood test for early detection of common female cancers. The test is suitable for general health screening and especially suitable for those individuals on Hormone Replacement Therapy. HRT can increase the risk of some female cancers. It is recommended as an annual test

For the blood test and results/referral service you will pay only one consultation fee of £125 in addition to the price for the test which is linked below.